The United States Department of Justice (DOJ) recently announced that Teva Pharmaceuticals USA Inc. and Teva Neuroscience Inc. will pay $450 million to resolve allegations of violating the ...
Teva Pharmaceuticals USA Inc. (Teva USA) and Teva Neuroscience Inc. (“Teva”) agreed to pay $450 million to resolve two matters that allege ...
Teva Pharmaceutical Industries Ltd has agreed to pay $450 million to resolve allegations it used charities that help cover ...
Teva Pharmaceuticals has agreed to pay $425 million to resolve allegations that the company ... submission of false claims to Medicare. 2. The settlement was reached after the government's review ...
On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its ...
Today's decision to impose an antitrust fine on Teva for disparagement and misuse of the patent system reaffirms the ...
Teva Pharmaceuticals has agreed to pay $450m to settle allegations that it violated several government acts and a raft of kickback allegations. On two serious occasions, it was alleged that Teva ...
Teva Pharmaceuticals TEVA-0.81%decrease; red down pointing triangle will pay $450 million to resolve allegations that ... Department on Thursday said the settlement amount was based on the company ...
Some two years after the European Commission accused Teva of meddling with the competition for its former multiple sclerosis blockbuster Copaxone, the other shoe has finally dropped. | The European ...
The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) ...
South Dakota will receive almost $300,000 as part of a settlement with global health company Apotex and Teva Pharmaceuticals ...
State attorneys general have reached a settlement over price-fixing by generic drugmakers for the first time since they began probing the issue a decade ago.